Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer

Abstract Estrogen signaling is crucial for breast cancer initiation and progression. Endocrine-based therapies comprising estrogen receptor (ER) modulators and aromatase inhibitors remain the mainstay of treatment. This study aimed at investigating the antitumor potential of the most potent compound...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dina M. El-Kersh, Shahira M. Ezzat, Maha M. Salama, Engy A. Mahrous, Yasmeen M. Attia, Mahmoud Salama Ahmed, Mohey M. Elmazar
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fed98f29b80b49bd8cc77afe4d8d0f8b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fed98f29b80b49bd8cc77afe4d8d0f8b
record_format dspace
spelling oai:doaj.org-article:fed98f29b80b49bd8cc77afe4d8d0f8b2021-12-02T13:27:04ZAnti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer10.1038/s41598-021-86599-z2045-2322https://doaj.org/article/fed98f29b80b49bd8cc77afe4d8d0f8b2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86599-zhttps://doaj.org/toc/2045-2322Abstract Estrogen signaling is crucial for breast cancer initiation and progression. Endocrine-based therapies comprising estrogen receptor (ER) modulators and aromatase inhibitors remain the mainstay of treatment. This study aimed at investigating the antitumor potential of the most potent compounds in citrus peels on breast cancer by exploring their anti-estrogenic and anti-aromatase activities. The ethanolic extract of different varieties of citrus peels along with eight isolated flavonoids were screened against estrogen-dependent breast cancer cell lines besides normal cells for evaluating their safety profile. Naringenin, naringin and quercetin demonstrated the lowest IC50s and were therefore selected for further assays. In silico molecular modeling against ER and aromatase was performed for the three compounds. In vivo estrogenic and anti-estrogenic assays confirmed an anti-estrogenic activity for the isolates. Moreover, naringenin, naringin and quercetin demonstrated in vitro inhibitory potential against aromatase enzyme along with anticancer potential in vivo, as evidenced by decreased tumor volumes. Reduction in aromatase levels in solid tumors was also observed in treated groups. Overall, this study suggests an antitumor potential for naringenin, naringin and quercetin isolated from citrus peels in breast cancer via possible modulation of estrogen signaling and aromatase inhibition suggesting their use in pre- and post-menopausal breast cancer patients, respectively.Dina M. El-KershShahira M. EzzatMaha M. SalamaEngy A. MahrousYasmeen M. AttiaMahmoud Salama AhmedMohey M. ElmazarNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Dina M. El-Kersh
Shahira M. Ezzat
Maha M. Salama
Engy A. Mahrous
Yasmeen M. Attia
Mahmoud Salama Ahmed
Mohey M. Elmazar
Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
description Abstract Estrogen signaling is crucial for breast cancer initiation and progression. Endocrine-based therapies comprising estrogen receptor (ER) modulators and aromatase inhibitors remain the mainstay of treatment. This study aimed at investigating the antitumor potential of the most potent compounds in citrus peels on breast cancer by exploring their anti-estrogenic and anti-aromatase activities. The ethanolic extract of different varieties of citrus peels along with eight isolated flavonoids were screened against estrogen-dependent breast cancer cell lines besides normal cells for evaluating their safety profile. Naringenin, naringin and quercetin demonstrated the lowest IC50s and were therefore selected for further assays. In silico molecular modeling against ER and aromatase was performed for the three compounds. In vivo estrogenic and anti-estrogenic assays confirmed an anti-estrogenic activity for the isolates. Moreover, naringenin, naringin and quercetin demonstrated in vitro inhibitory potential against aromatase enzyme along with anticancer potential in vivo, as evidenced by decreased tumor volumes. Reduction in aromatase levels in solid tumors was also observed in treated groups. Overall, this study suggests an antitumor potential for naringenin, naringin and quercetin isolated from citrus peels in breast cancer via possible modulation of estrogen signaling and aromatase inhibition suggesting their use in pre- and post-menopausal breast cancer patients, respectively.
format article
author Dina M. El-Kersh
Shahira M. Ezzat
Maha M. Salama
Engy A. Mahrous
Yasmeen M. Attia
Mahmoud Salama Ahmed
Mohey M. Elmazar
author_facet Dina M. El-Kersh
Shahira M. Ezzat
Maha M. Salama
Engy A. Mahrous
Yasmeen M. Attia
Mahmoud Salama Ahmed
Mohey M. Elmazar
author_sort Dina M. El-Kersh
title Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
title_short Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
title_full Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
title_fullStr Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
title_full_unstemmed Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
title_sort anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fed98f29b80b49bd8cc77afe4d8d0f8b
work_keys_str_mv AT dinamelkersh antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
AT shahiramezzat antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
AT mahamsalama antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
AT engyamahrous antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
AT yasmeenmattia antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
AT mahmoudsalamaahmed antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
AT moheymelmazar antiestrogenicandantiaromataseactivitiesofcitruspeelsmajorcompoundsinbreastcancer
_version_ 1718393070683160576